Think Surgical’s New FDA Clearance Is Bringing it Even Closer to Zimmer Biomet

The Fremont, CA-based company has won a nod from FDA for the Tmini Miniature Robotic system to be used with Zimmer Biomet’s Persona Personalized Knee System.

Omar Ford

September 6, 2024

1 Min Read
Image courtesy of Think Surgical

Think Surgical has won FDA clearance for the Tmini Miniature Robotic System to be used with Zimmer Biomet’s Persona Personalized Knee System.

The clearance closely follows Fremont, CA-based Think Surgical and Zimmer Biomet announcing a limited distribution agreement.

The availability of the Persona Knee System on an exclusive version of the TMINI System is a major milestone for Think Surgical, the company said.

Think Surgical said it is the only company offering a robotic system providing both an implant exclusive option with the Persona Knee System and an open implant platform for use with implants from multiple other manufacturers for total knee arthroplasty.

"Tmini addresses surgeon demand for ergonomic, wireless, handheld robotic systems and we believe this will accelerate adoption of robotics in knee procedures, particularly in the out-patient setting." said Think Surgical CEO, Stuart Simpson.

Think Surgical said that it offers robotic systems for joint replacement surgery that feature an open implant library, giving customers a compelling alternative to closed systems limited to a single manufacturer's implants.

The ability for surgeons to use implants from multiple implant manufacturers in combination with Think's robotic technology allows them to not only benefit from robotic-assisted surgery but also choose the implant best suited to each patient.

Related:Think Surgical Raises $100M for Orthopedic Surgical Robotic Products

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like